| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2015 | 2020 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1991 | 2018 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2012 | 2020 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2007 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2018 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2019 | |||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
nuclear paraspeckle assembly transcript 1 | 0.502 | 0.769 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2020 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2016 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2014 | |||||||||
|
microRNA 18a | 0.520 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2015 | |||||||||
|
microRNA 19a | 0.512 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | |||||||||
|
microRNA 22 | 0.496 | 0.808 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2019 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | |||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1996 | 1997 | |||||||||
|
RNA, 28S ribosomal N5 | 0.705 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 216b | 0.621 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 708 | 0.570 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
P2RX5-TAX1BP3 readthrough (NMD candidate) | 0.588 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
H3 histone pseudogene 12 | 0.603 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
long intergenic non-protein coding RNA 1152 | 0.729 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
competing endogenous lncRNA 3 for miR-645 | 0.531 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 |